共 60 条
[1]
Maricq HR(1993)Geographic variation in the prevalence of Raynaud’s phenomenon—Charleston, SC, USA vs Tarentaise, Savoie, France J Rheumatol 20 70-76
[2]
Carpentier PH(1957)Raynaud’s disease among women and girls Circulation 16 1012-1021
[3]
Weinrich MC(1929)Experiments relating to the peripheral mechanism involved in spasmodic arrest of the circulation in the fingers, a variety of Raynaud’s disease Heart 15 7-101
[4]
Gifford RW(1990)a aa a 2 -Adrenergic and 5-HT2 receptor hypersensitivity in Raynaud’s phenomenon J Vasc Med Biol 2 100-105
[5]
Hines EA(1996)Pharmacotherapy of Raynaud’s phenomenon Drugs 52 682-695
[6]
Lewis T(1983)Controlled double-blind trial of nifedipine in the treatment of Raynaud’s phenomenon N Engl J Med 308 880-883
[7]
Coffman JD(1989)The clinical effect of felodipine and nifedipine in Raynaud’s phenomenon Eur J Clin Pharmacol 37 191-192
[8]
Cohen RA(1991)Once daily felodipine in patients with primary Raynaud’s phenomenon Eur J Clin Pharmacol 40 313-315
[9]
Belch JJF(1989)The effect of isradipine, a new calcium-channel antagonist in patients with primary Raynaud’s phenomenon: a single-blind dose-response study Cardiovasc Drug Ther 3 397-401
[10]
Meilien H(1987)Inefficacy of diltiazem in the treatment of Raynaud’s phenomenon with associated connective tissue disease: a double blind placebo controlled study J Rheumatol 14 858-859.